Home›Bexagliflozin›Bexagliflozin + Ugt Enzyme Inducers

Does Bexagliflozin Interact with Ugt Enzyme Inducers?

Bexagliflozin and Ugt Enzyme Inducers have a moderate drug interaction according to U.S. FDA drug labeling data. UGT enzyme inducers may significantly reduce bexagliflozin exposure and lead to decreased efficacy. Consider adding another antihyperglycemic agent for additional glycemic control. The mechanism involves induction of ugt metabolism reducing bexagliflozin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Bexagliflozin Class
Sodium-Glucose Cotransporter 2 Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Bexagliflozin and Ugt Enzyme Inducers occurs because induction of ugt metabolism reducing bexagliflozin exposure. Clinically, this means ugt enzyme inducers may significantly reduce bexagliflozin exposure and lead to decreased efficacy. consider adding another antihyperglycemic agent for additional glycemic control. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Bexagliflozin and your doctor is considering prescribing Ugt Enzyme Inducers (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Bexagliflozin(Brenzavvy)+💊 Ugt Enzyme Inducers

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Sodium-Glucose Cotransporter 2 Inhibitor
Drug B class
—
Source
NLP:bexagliflozin

What this means in plain English

UGT enzyme inducers may significantly reduce bexagliflozin exposure and lead to decreased efficacy. Consider adding another antihyperglycemic agent for additional glycemic control.

About Bexagliflozin and Ugt Enzyme Inducers

Bexagliflozin is a Sodium-Glucose Cotransporter 2 Inhibitor. Bexagliflozin is also sold under the brand name Brenzavvy. Bexagliflozin is taken by mouth.

What the FDA label says

"Induction of UGT metabolism reducing bexagliflozin exposure"

📖 Source: NLP:bexagliflozin

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Bexagliflozin and Ugt Enzyme Inducers against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.